Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: A randomized, double-blind, comparative trial

Clinical Infectious Diseases

Volumn 47, Issue 5, 2008, Pages 651-658

  Abudalu, Mohammed ^a   Tyring, Stephen ^b,c   Koltun, William ^d   Bodsworth, Neil ^f   Hamed, Kamal ^e,f  

^a Clayton Research Institute   (United States)

^b University of Texas Health Science Center at Houston   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d Medical Center for Clinical Research   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR; VALACICLOVIR;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENITAL HERPES; HEADACHE; HUMAN; HYPOGLYCEMIA; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; VOMITING;

2-AMINOPURINE; ACYCLOVIR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; VALINE; YOUNG ADULT;

EID: 49449105464     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/590561     Document Type: Article

References (16)

1. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004; 11(Suppl 1):2A-23A.
2. Mertz GJ, Rosenthal SL, Stanberry LR. Editorial response: is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis 2003; 30:801-2.
3. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 2006; 296:964-73.
4. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186(Suppl):S3-28.
5. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121:847-54.
6. Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Recurrent genital herpes treatments and their impact on quality of life. Pharmacoeconomics 2003; 21:853-63.
7. Patel R, Boselli F, Cairo I, Barnett G, Price M, Wulf HC. Patients' perspectives on the burden of recurrent genital herpes. Int J STD AIDS 2001; 12:640-5.
8. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002; 34:958-62.
9. Strand A, Patel R, Wulf HC, Coates KM. International Valaciclovir HSV Study Group. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir. Sex Transm Infect 2002; 78:435-9.
10. Wald A, Carrell D, Remington M, Kexel E, Zeh J, Corey L. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection. Clin Infect Dis 2002; 34:944-8.
11. Bodsworth N, Bloch M, McNulty A, et al. 2-Day versus 5-day famciclovir as treatment of recurrences of genital herpes - results of the FaST study. Sexual Health [in press].
12. Aoki FY, Tyring S, Diaz-Mitoma F, et al. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double blind, placebo trial. Clin Infect Dis 2006; 42:8-13.
13. Brown ZA, Kern ER, Spruance SL, Overall JC Jr. Clinical and virologic course of herpes simplex genitalis. West J Med 1979; 130:414-21.
14. Beauman JG. Genital herpes: a review. Am Fam Physician 2005; 72:1527-34.
15. Aoki F, Tyring S, Diaz-Mitoma F, Gao J, Hamed K. Patient-initiated high-dose oral famciclovir for 1 day shortens the duration of recurrent genital herpes lesions [abstract V1839]. In: Program and abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington, DC). Washington, DC: American Society for Microbiology, 2005.
16. Spruance S, Aoki FY, Tyring S, Stanberry L, Whitley R, Hamed K. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract 2007; 56:30-6.